Shirley Lee Lecher

Shirley Lee Lecher

Auto-generated profile, based on publicly available information

Shirley Lee Lecher

Affiliation Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
VAVictor Akelo
Victor Akelo
SGSonali Girde
Sonali Girde
CBCraig B. Borkowf
Craig B. Borkowf
FAFrank Angira
Frank Angira
KAKevin Achola
Kevin Achola
SLShirley Lee Lecher
Shirley Lee Lecher
Preventing unintended pregnancies among HIV-positive women through family planning (FP) reduces pregnancy-related morbidity and mortality, decreases the number of pediatric HIV infections, and has also proven to be a cost-effective way to prevent mother-to-child HIV transmission. A key element of a comprehensive HIV prevention agenda, aimed at avoiding unintended pregnancies, is recognizing the attitudes towards FP among HIV-positive women and their spouse or partner. In this study, we analyze FP attitudes among HIV-infected pregnant women enrolled in a PMTCT clinical trial in Western Kenya. Baseline data were collected on 522 HIV-positive pregnant women using structured questionnaires. Associations between demographic variables and the future intention to use FP were examined using Fisher's exact tests and permutation tests. Most participants (87%) indicated that they intended to use FP. However, only 8% indicated condoms as a preferred FP method, and 59% of current pregnancies were unintended. Factors associated with positive intentions to use FP were: marital status (p = 0.04), having talked to their spouse or partner about FP (p<0.001), perceived spouse or partner approval of FP (p<0.001), previous use of a FP method (p = 0.006), attitude toward the current pregnancy (p = 0.02), disclosure of a sexually transmitted infection (STI) diagnosis (p = 0.03) and ethnic group (p = 0.03). A significant gap exists between future FP intentions and current FP practices. Support and approval by the spouse or partner are key elements of FP intentions. Counseling services should be offered to both members of a couple to increase FP use, especially given the high number of unplanned pregnancies among HIV-positive women. Condoms should be promoted as part of a dual use method for HIV and STI prevention and for contraception. Integration of individual and couple FP services into routine HIV care, treatment and support services is needed in order to avoid unintended pregnancies and to prevent mother-to-child HIV transmission.

29 September 2022 in Journal of the International AIDS Society
Verified
Journal Article
Open access
SFShannon M. Farley
Shannon M. Farley
CWChunhui Wang
Chunhui Wang
RBRachel M. Bray
Rachel M. Bray
ALAndrea Jane Low
Andrea Jane Low
SDStephen Delgado
Stephen Delgado
JJJessica E. Justman
Jessica E. Justman
Introduction: Achieving optimal HIV outcomes, as measured by global 90‐90‐90 targets, that is awareness of HIV‐positive status, receipt of antiretroviral (ARV) therapy among aware and viral load (VL) suppression among those on ARVs, respectively, is critical. However, few data from sub‐Saharan Africa (SSA) are available on older people (50+) living with HIV (OPLWH). We examined 90‐90‐90 progress by age, 15–49 (as a comparison) and 50+ years, with further analyses among 50+ (55–59, 60–64, 65+ vs. 50–54), in 13 countries (Cameroon, Cote d'Ivoire, Eswatini, Ethiopia, Kenya, Lesotho, Malawi, Namibia, Rwanda, Tanzania, Uganda, Zambia and Zimbabwe).Methods: Using data from nationally representative Population‐based HIV Impact Assessments, conducted between 2015and 2019, participants from randomly selected households provided demographic and clinical information and whole blood specimens for HIV serology, VL and ARV testing. Survey weighted outcomes were estimated for 90‐90‐90 targets. Country‐specific Poisson regression models examined 90‐90‐90 variation among OPLWH age strata.Results: Analyses included 24,826 HIV‐positive individuals (15–49 years: 20,170; 50+ years: 4656). The first, second and third 90 outcomes were achieved in 1, 10 and 5 countries, respectively, by those aged 15–49, while OPLWH achieved outcomes in 3, 13 and 12 countries, respectively. Among those aged 15–49, women were more likely to achieve 90‐90‐90 targets than men; however, among OPLWH, men were more likely to achieve first and third 90 targets than women, with second 90 achievement being equivalent. Country‐specific 90‐90‐90 regression models among OPLWH demonstrated minimal variation by age stratum across 13 countries. Among OLPWH, no first 90 target differences were noted by age strata; three countries varied in the second 90 by older age strata but not in a consistent direction; one country showed higher achievement of the third 90 in an older age stratum.Conclusions: While OPLWH in these 13 countries were slightly more likely than younger people to be aware of their HIV‐positive status (first 90), this target was not achieved in most countries. However, OPLWH achieved treatment (second 90) and VL suppression (third 90) targets in more countries than PLWH <50. Findings support expanded HIV testing, prevention and treatment services to meet ongoing OPLWH health needs in SSA.

28 May 2021 in MMWR. Morbidity and Mortality Weekly Report
Verified
Journal Article
Open access
SLShirley Lee Lecher
Shirley Lee Lecher
MNMary Naluguza
Mary Naluguza
CMChristina Mwangi
Christina Mwangi
JNJonathan N’tale
Jonathan N’tale
DEDianna Edgil
Dianna Edgil
HAHeather Alexander
Heather Alexander
This report describes the impact of COVID-19 on HIV viral load testing in PEPFAR-supported countries.

14 February 2017 in AIDS and Behavior
Verified
Journal Article
Closed access
PDF file
VMVictor Mudhune
Victor Mudhune
RGRoman Gvetadze
Roman Gvetadze
SGSonali Girde
Sonali Girde
RNRichard Ndivo
Richard Ndivo
FAFrank Angira
Frank Angira
SLShirley Lee Lecher
Shirley Lee Lecher

7 November 2014 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
JOJohn O Okanda
John O Okanda
CBCraig B Borkowf
Craig B Borkowf
SGSonali Girde
Sonali Girde
TTTimothy K Thomas
Timothy K Thomas
SLShirley Lee Lecher
Shirley Lee Lecher
One of the most effective ways to promote the prevention of mother-to-child transmission (PMTCT) of HIV-1 in resource-limited settings is to encourage HIV-positive mothers to practice exclusive breastfeeding (EBF) for the first 6 months post-partum while they receive antiretroviral therapy (ARV). Although EBF reduces mortality in this context, its practice has been low. We studied the rate of adherence to EBF and assessed associated maternal and infant characteristics using data from a phase II PMTCT clinical trial conducted in Western Kenya which included a counseling intervention to encourage EBF by all participants.

1 August 2024 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
DCDeborah Carpenter
Deborah Carpenter
MHMarisa Hast
Marisa Hast
NBNicole Buono
Nicole Buono
SHSusan Hrapcak
Susan Hrapcak
KSKimi Sato
Kimi Sato
SLShirley Lecher
Shirley Lecher
The early period of the COVID-19 pandemic limited access to HIV services for children and adolescents living with HIV (C/ALHIV). To determine progress in providing care and treatment services, we describe viral load coverage (VLC) and suppression (VLS) (<1000 copies/ mL) rates during the COVID-19 pandemic in 12 United States President’s Emergency Plan for AIDS Relief (PEPFAR)-supported countries. Data for children (0–9 years) and adolescents (10–19 years) on VLC and VLS were analyzed for 12 sub-Saharan African (SSA) countries between 2019 (pre-COVID-19) and 2020 (during COVID-19). We report the number of viral load (VL) tests, and percent change in VLC and VLS for patients on ART. For 12 countries, 181,192 children had a VL test during the pre-COVID-19 period compared with 177,683 December 2020 during COVID-19. VLC decreased from 68.8% to 68.3% overall. However, 9 countries experienced an increase ranging from a 0.7%-point increase for Tanzania and Zimbabwe to a 15.3%-point increase for Nigeria. VLS increased for all countries from 71.2% to 77.7%. For adolescents the number with a VL test increased from 377,342 to 402,792. VLC decreased from 77.4% to 77.1%. However, 7 countries experienced an increase ranging from 1.8% for Mozambique to 13.8% for Cameroon. VLS increased for all countries from 76.8% to 83.8%. This analysis shows variation in HIV VLC across 12 SSA countries. VLS consistently improved across all countries demonstrating resilience of countries during 2020. Countries should continue to improve clinical outcomes from C/ALHIV despite service disruptions that may occur during pandemic response.